Russ Burrell
Commercial Director, Xalkori & New Business
Management
Emd Serono
Canada
Biography
Russ Burrell has over 20 years experience in biopharmaceutical marketing, sales, and business and product development.Russ joined Serono in 1997 in Fertility and has worked in MS, Endocrinology, Dermatology, oncology and business development, where Russ was responsible for the five-year distribution and promotion agreement with Ipsen for SOMATULINE AUTOGEL (lanreotide).Previous leadership roles within EMD Serono include: Director of Marketing, Neurology (2000–2003); Business Unit Director, Dermatology & Metabolic Endocrinology (2003–2005); and Therapeutic Area Director, Dermatology (2005–2009). Prior to EMD Serono, Russ worked with A.C. Neilsen, Ortho Pharmaceuticals, Ortho-McNeil, and Janssen Ortho.In his current role as Commercial Director, XALKORI & New Business, Russ leads the EMD team supporting XALKORI (crizotinib) — through a partnership with Pfizer Canada. He is also responsible for new business development and is leading the planning to bring Avelumab to Canada for EMD.
Research Interest
Endocrinology, Dermatology, oncology and business development,
